Summary
In a study of 102 women (Arabs and Asians) with hirsutism, polycystic ovary syndrome was diagnosed in 93 patients (91%) including 26 cases with hirsutism and regular menstrual periods. In more than half of the cases the diagnosis was made on the basis of transabdominal ultrasonography, which was the single test with the highest yield. Luteinising hormone hyperresponsiveness to gonadotropin-releasing hormone was positive in only seven of 50 patients tested.
Late onset congenital adrenal hyperplasia due to 21-hydroxylase deficiency was identified in two cases, thus forming a prevalence of 8% in those who underwent adrenocorticotropin stimulation. In one case, polycystic ovary syndrome was an associated condition. In this study of a population of women with hirsutism and regular menses, the majority had polycystic ovaries. It is suggested that the term 'idiopathic or racial' hirsutism should not be applied unless a thorough evaluation has failed to reveal a diagnosable underlying disorder. 
Results
Of the 102 patients, 72 were Emirian nationals, 18 were Arab expatriates (non-UAE Arabs), and 12 were Asians from the Indian subcontinent. Their age ranged from 14-37 years with an average of 22.3 years. Sixty-three patients were obese (body mass index > 25 kg/M2). In the 50 patients who underwent a gonadatropinreleasing hormone stimulation test, an enhanced response as defined by Marshall et al" (ie, at least a four-fold rise of the basal level of luteinising hormone at 20 minutes after the gonadotropin-releasing hormone injection) was observed in only seven patients (14%). Of these, only one had abnormal ultrasonographic findings consistent with polycystic ovary syndrome. An enhanced response of 17-hydroxyprogesterone (10 times or more the basal level) to adrenocorticotropin stimulation was obtained in only two cases ofthe 25 patients tested. These two patients were thus diagnosed as late-onset congenital adrenal hyperplasia due to 21-hydroxylase deficiency. In the one patient in whom 17-hydroxyprogesterone suppression was attempted, the basal level was suppressible by dexamethasone; this patient also had ultrasonographic features consistent with polycystic ovary syndrome. In the whole group, 93 patients (91%) were diagnosed as having polycystic ovary syndrome alone. These included 26 patients who had previously been considered to have idiopathic hirsutism (hirsutism with regular menstrual periods). 
In our group the relatively high yield of positive pelvic ultrasonography in the diagnosis of polycystic ovary syndrome appeared to make it the investigation of choice in the evaluation of hirsutism. The result is comparable to that reported in a series of 350 patients in the UK (60o%). Some authors advocate the use of the adrenocorticotropin stimulation test in every patient with hirsutism,' but we tend to believe that their opinion may be influenced by the fact that late-onset congenital adrenal hyperplasia is frequently encountered in their community. The test is not cost-effective and the majority of our patients have radiological and hormonal changes in keeping with polycystic ovary syndrome, thus performing the adrenocorticotropin stimulation test in hirsutism routinely is probably of limited practical value in this community. The test is better reserved for those patients who do not respond to the conventional treatment for polycystic ovary syndrome. Finally, there is a need for further studies to evaluate hirsuitism in each major ethnic group of this community. The magnitude of 'racial hirsutism' remains obscure. Large number of families will need to be evaluated in order to determine its prevalence.
We thank Dr M Al Bitar and Mrs Mariam Mathew for their assistance in this study.
